Headline
The latest stories from AHA Today.
CMS released guidance for non-federal governmental plans implementing the Families First Coronavirus Response Act requirement to cover COVID-19 diagnostic testing and certain related items and services without cost-sharing, prior authorization or other medical management restrictions during the…
The Food and Drug Administration reissued emergency use authorizations that revise policy on the types of respirators that can be decontaminated for reuse.
The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response shared resources for protecting community hospitals and providing care during civil unrest.
Eligible hospitals can apply through July 6 to participate in the Medicare Direct Contracting Model, which will offer two primary care payment options for hospitals beginning next April.
After losing 1.5 million jobs in April, the health care field added 312,000 jobs in May, increasing 2% to a seasonally adjusted 15.2 million, the Bureau of Labor Statistics reported.
The Food and Drug Administration released COVID-19 performance data for four more antibody test kits. The results come from the first collaboration between FDA, the National Institute of Health’s National Cancer Institute, Centers for Disease Control and Prevention and Biomedical Advanced Research…
The Department of Health and Human Services released guidance specifying what data laboratories must report to HHS along with their COVID-19 test results, the method for submission, and the data reporting and transmission requirements.
The AHA is sharing new case studies, leadership blogs and tools every day this week to mark Community Health Improvement Week.
The Food and Drug Administration this week released guidance for institutional review boards seeking clarity regarding the key factors and procedures they should consider when reviewing requests by physicians and others for individual patient access to investigational drugs.
Social distancing interventions started earlier in the COVID-19 epidemic appear to delay the epidemic curve while interventions started later appear to flatten it, according to a new study published in the Centers for Disease Control and Prevention’s Emerging Infectious Diseases Journal.